MedicarePartD.guide

A non-government resource built from CMS public data

mResvia on AARP Medicare Rx Preferred from UHC (S5921-388)

RSV vaccine

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 0.5 per 1 days.

$1,534.18
Patient pays / month, after deductible
$1,643.38
Patient pays / month, before the $130.00 deductible
$4,602.53
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

MRESVIA 50 ug/.5mL Suspension at a preferred retail pharmacy, from the plan's negotiated price of $9,588.60 for a month.

Prior authRequired on the covered form· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)

Other Part D vaccines on this plan

Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5921-388